Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/216698
Title: | Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries |
Author: | Leigh, Jeanne Parsons Moss, Stephana J. White, Trenton M. Picchio, Camila A. Rabin, Kenneth Ratzan, Scott Wyka, Katarzyna El-Mohandes, Ayman Lazarus, Jeffrey V. |
Keywords: | COVID-19 SARS-CoV-2 Vacunes Personal sanitari Percepció del risc Seguretat dels productes COVID-19 SARS-CoV-2 Vaccines Medical personnel Risk perception Product safety |
Issue Date: | 29-Jul-2022 |
Publisher: | Elsevier B.V. |
Abstract: | Background: Several early COVID-19 studies aimed to assess the potential acceptance of a vaccine among healthcare providers, but relatively few studies of this population have been published since the vaccines became widely available. Vaccine safety, speed of development, and low perceived disease risk were commonly cited as factors for COVID-19 vaccine hesitancy among this group. Purpose and methods: In a secondary analysis based on a cross-sectional, structured survey, the authors aimed to assess the associations between self-reported vaccine hesitancy and a number of sociodemographic and COVID-19 vaccine perception factors using data from 3,295 healthcare providers (physicians, nurses, community health workers, other healthcare providers) in 23 countries. Findings: 494 (15.0%) of the participants reported vaccine hesitancy, of whom 132 (4.0%) would outright refuse to accept a COVID-19 vaccine. Physicians were the least hesitant. Vaccine hesitancy was more likely to occur among those with less than the median income and, to a lesser degree, younger age. Safety and risk concerns and lack of trust that vaccines would be equitably distributed were strongly associated with hesitancy, less so were concerns about the efficacy of COVID-19 vaccines. Interpretation: Findings suggest a need to address safety and risk concerns through tailored messaging, training, and/or incentive approaches among healthcare providers, as well as the need for international and national vaccination efforts to ensure equitable distribution. |
Note: | Reproducció del document publicat a: https://doi.org/10.1016/j.vaccine.2022.04.097 |
It is part of: | Vaccine, 2022, vol. 40, num.31, p. 4081-4089 |
URI: | https://hdl.handle.net/2445/216698 |
Related resource: | https://doi.org/10.1016/j.vaccine.2022.04.097 |
ISSN: | 0264-410X |
Appears in Collections: | Articles publicats en revistes (Medicina) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
870155.pdf | 1.13 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License